de Reijke TM - Search Results

1

Prospective multicentre evaluation of PCA3 and TMPRSS2-ERG gene fusions as diagnostic and prognostic urinary biomarkers for prostate cancer.

Leyten GH, Hessels D, Jannink SA, Smit FP, de Jong H, Cornel EB, de Reijke TM, Vergunst H, Kil P, Knipscheer BC, van Oort IM, Mulders PF, Hulsbergen-van de Kaa CA, Schalken JA. Leyten GH, et al. Among authors: de reijke tm, de jong h. Eur Urol. 2014 Mar;65(3):534-42. doi: 10.1016/j.eururo.2012.11.014. Epub 2012 Nov 15. Eur Urol. 2014. PMID: 23201468

2

Incidental carcinoma of the prostate.

van Andel G, Vleeming R, Kurth K, de Reijke TM. van Andel G, et al. Among authors: de reijke tm. Semin Surg Oncol. 1995 Jan-Feb;11(1):36-45. doi: 10.1002/ssu.2980110106. Semin Surg Oncol. 1995. PMID: 7538693 Review.

3

The detection of prostatic carcinoma. 4- or 7-MHz transrectal ultrasonography?

Vleeming R, Noordzij JW, de Reijke TM, Kurth KH. Vleeming R, et al. Among authors: de reijke tm. World J Urol. 1993;11(1):66-8. doi: 10.1007/BF00182174. World J Urol. 1993. PMID: 8490670

4

Urinary cytokines during intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer: processing, stability and prognostic value.

de Reijke TM, de Boer EC, Kurth KH, Schamhart DH. de Reijke TM, et al. Among authors: de boer ec. J Urol. 1996 Feb;155(2):477-82. J Urol. 1996. PMID: 8558640 Clinical Trial.

5

Does prostate-specific antigen density alter decision making on biopsy?

Vleeming R, de Craen AJ, de Reijke TM, van Andel G, Kurth KH. Vleeming R, et al. Among authors: de craen aj, de reijke tm. Eur Urol. 1996;29(1):10-14. doi: 10.1159/000473710. Eur Urol. 1996. PMID: 8821683

6

Long-term efficacy and safety of nilutamide plus castration in advanced prostate cancer, and the significance of early prostate specific antigen normalization. International Anandron Study Group.

Dijkman GA, Janknegt RA, De Reijke TM, Debruyne FM. Dijkman GA, et al. Among authors: de reijke tm. J Urol. 1997 Jul;158(1):160-3. doi: 10.1097/00005392-199707000-00051. J Urol. 1997. PMID: 9186345 Clinical Trial.

7

Bladder wash cytology, quantitative cytology, and the qualitative BTA test in patients with superficial bladder cancer.

Van der Poel HG, Van Balken MR, Schamhart DH, Peelen P, de Reijke T, Debruyne FM, Schalken JA, Witjes JA. Van der Poel HG, et al. Urology. 1998 Jan;51(1):44-50. doi: 10.1016/s0090-4295(97)00496-2. Urology. 1998. PMID: 9457287

8

The Bard BTA test: its mode of action, sensitivity and specificity, compared to cytology of voided urine, in the diagnosis of superficial bladder cancer.

Schamhart DH, de Reijke TM, van der Poel HG, Witjes JA, de Boer EC, Kurth K, Schalken JA. Schamhart DH, et al. Among authors: de boer ec, de reijke tm. Eur Urol. 1998 Aug;34(2):99-106. doi: 10.1159/000019692. Eur Urol. 1998. PMID: 9693243 Clinical Trial.

9

Considerations regarding prostate biopsies.

Beerlage HP, de Reijke TM, de la Rosette JJ. Beerlage HP, et al. Among authors: de reijke tm, de la rosette jj. Eur Urol. 1998 Oct;34(4):303-12. doi: 10.1159/000019746. Eur Urol. 1998. PMID: 9748677 Review.

10

Urinary interleukin-2 monitoring during prolonged bacillus Calmette-Guerin treatment: can it predict the optimal number of instillations?

de Reijke TM, De Boer EC, Kurth KH, Schamhart DH. de Reijke TM, et al. Among authors: de boer ec. J Urol. 1999 Jan;161(1):67-71. doi: 10.1097/00005392-199901000-00024. J Urol. 1999. PMID: 10037371 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

264 results

Search Page

Filters